0001127602-23-002457.txt : 20230127
0001127602-23-002457.hdr.sgml : 20230127
20230127163846
ACCESSION NUMBER: 0001127602-23-002457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230126
FILED AS OF DATE: 20230127
DATE AS OF CHANGE: 20230127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCubbin Quentin
CENTRAL INDEX KEY: 0001842009
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 23563739
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 10 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-01-26
0001703647
Frequency Therapeutics, Inc.
FREQ
0001842009
McCubbin Quentin
75 HAYDEN AVE
SUITE 300
LEXINGTON
MA
02421
1
Chief Manufacturing Officer
Restricted Stock Unit
2023-01-26
4
A
0
105000
0
A
Common Stock
105000
105000
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The restricted stock units will vest in four equal annual installments beginning on January 26, 2024.
/s/ James P. Abely, Attorney-in-Fact for Quentin McCubbin
2023-01-27